Table 1. Patient's characteristics according to the presence of prostatic inflammation.
| Overall | Inflammatory score < 7 | Inflammatory score ≥ 7 | p | |
|---|---|---|---|---|
| Patients | 94 | 60/94 (64%) | 34/94 (36%) | |
| Age (years) | 69,6 ± 6.8 (69; 65-75) | 69.6±7.1 (69; 66-75) | 69.6±6.5 (71; 65-74.5) | 0.779 |
| BMI (kg/m2) | 22,9±2.8 (22.4; 21-24) | 22.7±2.9 (22.6; 20-24) | 23.1±2.8 (22.4; 21-24) | 0.484 |
| PSA (ng/ml) | 6±4 (5.2; 2.7-9.1) | 6.5±5.2 (5; 2-9.2) | 6±4 (4.7; 3.3-9) | 0.865 |
| TRUS volume (ml) | 71 ±17 (66; 50-96) | 70±28.1 (65; 50-89) | 65.8±22.5 (59.5; 50-82) | 0.247 |
| IPSS | 18.9 ±6.7 (18; 13-24) | 17.4±6.1 (16; 13-23) | 21.4±7 (24; 16-2721) | 0.004 |
| IPSS voiding | 9.3±3.7 (10; 6-12) | 8.9±3.5 (8; 6-12) | 10.1±3.9 (11; 6-12) | 0.123 |
| IPSS storage | 9 ± 4 (9.5; 6-12) | 8.6±4.1 (7.5; (6-12) | 10.5 ± 3.9 (11; 9-13) | 0.018 |
| Qmax (ml/s) | 8.7±2.8 (8.2; 6.1-10.6) | 6±1 (6; 4-6) | 8.7±2.9 (9; 6-10) | 0.756 |
| PVR (ml) | 44.6±38.4 (37.5; 17.5-69.2) | 33±15 (30; 20-50) | 43.7±49.4 (30; 0-88) | 0.421 |
Data are presented as mean ± DS (median; IQR); BMI: body mass index; PSA: prostate specific antigen; TRUS: trans rectal ultrasound; IPSS: International Prostate Symptoms Score; Qmax: maximum urine flow; PVR: post voiding residual.